首页> 外文OA文献 >Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

【2h】

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

机译：帕妥珠单抗，曲妥珠单抗和多西他赛治疗HER2阳性转移性乳腺癌的老年患者：亚组分析来自一项随机，双盲，安慰剂对照的III期临床试验（CLEOPATRA）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
David Miles; José Baselga; Dino Amadori; Patrapim Sunpaweravong; Vladimir Semiglazov; Adam Knott; Emma Clark; Graham Ross; Sandra M. Swain;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类
入库时间 2022-08-20 20:27:48

相似文献

外文文献
中文文献
专利

1. Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: Subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA) [J] . MilesD., BaselgaJ., AmadoriD., Breast cancer research and treatment. . 2013,第1期

机译：帕妥珠单抗，曲妥珠单抗和多西他赛治疗HER2阳性转移性乳腺癌的老年患者：亚组分析来自一项随机，双盲，安慰剂对照的III期临床试验（CLEOPATRA）
2. A Phase II, Randomized, Double-Blind, Placebo-Controlled Registration Trial to Evaluate the Efficacy and Safety of Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxe! in Patients With Previously Untreated HER2-Positive Metastatic Breast Cancer (CLEOPATRA) [J] . Clinical advances in hematology & oncology: H&O . 2012,第Suppla2期

机译：II期，随机，双盲，安慰剂对照的注册试验，用于评估帕妥珠单抗+曲妥珠单抗+多西他赛与安慰剂+曲妥珠单抗+多西他赛的疗效和安全性！未经治疗的HER2阳性转移性乳腺癌（CLEOPATRA）患者中
3. Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: A randomized, double-blind, placebo-controlled phase III study [J] . SwainS.M., EwerM.S., CortésJ., The oncologist . 2013,第3期

机译：帕妥珠单抗加曲妥珠单抗加多西紫杉醇对CLEOPATRA HER2阳性转移性乳腺癌患者的心脏耐受性：一项随机，双盲，安慰剂对照的III期研究
4. Effects of laser immunotherapy on late-stage, metastatic breast cancer patients in a Phase Ⅱ clinical trial [C] . Gabriela L. Ferrel, Feifan Zhou, Xiaosong Li, Biophotonics and immune responses IX . 2014

机译：Ⅱ期临床试验中激光免疫疗法对晚期转移性乳腺癌患者的影响
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab trastuzumab and docetaxel: subgroup analyses from a randomized double-blind placebo-controlled phase III trial (CLEOPATRA) [O] . David Miles, José Baselga, Dino Amadori, -1

机译：帕妥珠单抗曲妥珠单抗和多西他赛治疗HER2阳性转移性乳腺癌的老年患者：亚组分析来自一项随机双盲安慰剂对照的III期临床试验（CLEOPATRA）
7. Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA [O] . S.M. Swain, J. Baselga, D. Miles, 2014

机译：用Pertuzumab，Trastuzumab和Docetaxel治疗的Her2阳性转移性乳腺癌患者中枢神经系统转移的发病率：随机期III研究结果结果

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

著录项

相似文献

相关主题

期刊订阅